Skip to main content
Clinical Trials/JPRN-UMIN000022592
JPRN-UMIN000022592
Completed
未知

Evaluation of early prediction using 18F-FDG PET/CT for patients with Iodine-131 refractory differentiated thyroid carcinoma treated with lenvatinib - Early Prediction using 18F-FDG PET/CT for patients with differentiated thyroid carcinoma treated with lenvatinib

Department of Medical Oncology, Hokkaido University Graduate School of Medicine0 sites22 target enrollmentJune 6, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
differentiated thyroid carcinoma
Sponsor
Department of Medical Oncology, Hokkaido University Graduate School of Medicine
Enrollment
22
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 6, 2016
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Medical Oncology, Hokkaido University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Medullary or undifferentiated thyroid carcinoma 2\) Ever treated with chemotherapy 3\) Double cancer 4\) Poor physical status 5\) Severe complication 6\) Fasting blood glucose over 150 mg/dl 7\) Brain metastasis or vascular thrombus requiring treatment 8\) Inappropriate to perform 18F\-FDG PET/CT or CT due to complications 9\) Pregnanant or nursing woman 10\) Other inappropriate patients judged byinvestigators

Outcomes

Primary Outcomes

Not specified

Similar Trials